EVMN
Evommune, Inc.
8.50$
-3.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 97.3% | 97.3% | 97.0% | 98.6% | 95.6% | 68.2% | 66.9% | 67.6% | |
| – | – | 21.4% | 21.4% | 10.2% | 64.3% | 31.7% | 19.6% | 15.0% | 19.9% | |
| – | – | 94.7% | 94.7% | 86.4% | 90.2% | 90.0% | 66.3% | 65.6% | 66.5% | |
| – | – | – | – | – | – | – | – | 0.3% | – | |
| – | – | – | – | – | – | – | – | 0.4% | – | |
| – | – | 37.5% | 289.6% | 382.5% | 278.0% | 316.6% | 8.6% | 5.6% | 8.1% | |
| – | – | 36.8% | 36.8% | 39.3% | 10.5% | 12.3% | 8.0% | 3.3% | 5.8% | |
| – | – | 1.1% | 0.6% | 1.3% | 0.5% | 0.6% | 0.3% | 0.6% | 0.4% | |
| – | – | 10.9% | 10.9% | 13.5% | 3.8% | 4.2% | 3.4% | 1.3% | 1.7% | |
| – | – | 62.5% | 62.5% | -282.5% | -178.0% | -216.6% | 91.4% | 94.4% | 91.9% | |
| – | – | -200.1% | -200.1% | -297.7% | -187.4% | -228.1% | -98.3% | -75.3% | -91.1% | |
| – | – | – | 39.5% | 53.7% | 31.3% | 37.3% | 14.0% | 10.4% | 12.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.